MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding MoonLake Immunotherapeutics changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 125 | 114 | −11 |
| Shares | 59.3M | 59.5M | +192.3K (+0.3%) |
| Value | $3.53B | $2.99B | −$539.2M (−15.3%) |
New holders (22)
Institutions that held MoonLake Immunotherapeutics at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (33)
Institutions that held MoonLake Immunotherapeutics at the end of Q4 2023 and filed for Q1 2024 without it.